[HIV-associated Neuropathies]

Overview

Journal Nervenarzt

Specialty Neurology

Date 2010 Mar 3

PMID 20195565

Citations 4

Authors

K Hahn

I W Husstedt

Affiliations

Soon will be listed here.

Abstract

Human immunodeficiency virus (HIV)-associated polyneuropathy has become the most common neurological complication of HIV infection and is one of the main risk factors for development of a neuropathy worldwide. Therefore HIV should always be considered as an underlying cause in patients with neuropathy. Many types of peripheral neuropathies are seen in HIV infection depending on the stage of infection. The inflammatory demyelinating neuropathies both acute (Guillain-Barré syndrome, GBS) and chronic (chronic inflammatory demyelinating neuropathy, CIDP) occur mainly at the time of seroconversion or early in the course of the disease while syndromes associated with opportunistic infections like CMV (i.e. polyradiculoneuropathy) occur in the late phase of HIV infection and are related to the loss of immune function. Distal symmetrical polyneuropathy (DSP) is the most common neuropathy in HIV-infected patients. We review the clinical manifestations, epidemiology, clinical diagnostics, pathophysiology and management strategies for HIV-associated polyneuropathies.

Citing Articles

A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.

Moodley K, Bill P, Patel V Neurol Neuroimmunol Neuroinflamm. 2017; 4(2):e315.

PMID: 28054000 PMC: 5182055. DOI: 10.1212/NXI.0000000000000315.

The HIV-1 transgenic rat model of neuroHIV.

Vigorito M, Connaghan K, Chang S Brain Behav Immun. 2015; 48:336-49.

PMID: 25733103 PMC: 4753047. DOI: 10.1016/j.bbi.2015.02.020.

Acute hemiplegia as a rare presentation of infantile Guillain-Barre syndrome.

Al-Mendalawi M Saudi Med J. 2014; 35(11):1419.

PMID: 25399226 PMC: 4362134.

Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.

Sbiera S, Dexneit T, Reichardt S, Michel K, van den Brandt J, Schmull S PLoS One. 2011; 6(9):e24345.

PMID: 21912688 PMC: 3166315. DOI: 10.1371/journal.pone.0024345.

References

Hahn K, Triolo A, Hauer P, McArthur J, Polydefkis M . Impaired reinnervation in HIV infection following experimental denervation. Neurology. 2007; 68(16):1251-6. DOI: 10.1212/01.wnl.0000261245.36884.7c. View

Apostolski S, McAlarney T, Hays A, Latov N . Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1. Immunol Invest. 1994; 23(1):47-52. DOI: 10.3109/08820139409063432. View

Simpson D, Dorfman D, Olney R, McKinley G, Dobkin J, So Y . Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology. 1996; 47(5):1254-9. DOI: 10.1212/wnl.47.5.1254. View

Pettersen J, Jones G, Worthington C, Krentz H, Keppler O, Hoke A . Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol. 2006; 59(5):816-24. DOI: 10.1002/ana.20816. View

Martin C, Solders G, Sonnerborg A, Hansson P . Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology. 2000; 54(11):2120-7. DOI: 10.1212/wnl.54.11.2120. View

Polydefkis M, Yiannoutsos C, Cohen B, Hollander H, Schifitto G, Clifford D . Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002; 58(1):115-9. DOI: 10.1212/wnl.58.1.115. View

Hahn K, Arendt G, Braun J, Von Giesen H, Husstedt I, Maschke M . A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004; 251(10):1260-6. DOI: 10.1007/s00415-004-0529-6. View

Franco-Paredes C, Rebolledo P, Folch E, Hernandez I, Del Rio C . Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read. 2002; 12(9):408-13. View

Evans S, Simpson D, Kitch D, King A, Clifford D, Cohen B . A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS One. 2007; 2(6):e551. PMC: 1919427. DOI: 10.1371/journal.pone.0000551. View

10.

Apostolski S, McAlarney T, Quattrini A, Levison S, Rosoklija G, Lugaressi A . The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol. 1993; 34(6):855-63. DOI: 10.1002/ana.410340616. View

11.

Estanislao L, Carter K, Mcarthur J, Olney R, Simpson D . A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr. 2004; 37(5):1584-6. DOI: 10.1097/00126334-200412150-00010. View

12.

Fuller G, Gill S, Guiloff R, Kapoor R, Lucas S, Sinclair E . Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet. 1990; 335(8680):48-9. DOI: 10.1016/0140-6736(90)90172-2. View

13.

Anders H, Weiss N, Bogner J, Goebel F . Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect. 1998; 36(1):29-33. DOI: 10.1016/s0163-4453(98)92982-6. View

14.

Hahn K, Robinson B, Anderson C, Li W, Pardo C, Morgello S . Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol. 2008; 210(1):30-40. PMC: 2270478. DOI: 10.1016/j.expneurol.2007.06.015. View

15.

Moulignier A, Authier F, Baudrimont M, Pialoux G, Belec L, Polivka M . Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997; 41(4):438-45. DOI: 10.1002/ana.410410406. View

16.

Tagliati M, Grinnell J, Godbold J, Simpson D . Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999; 56(1):84-9. DOI: 10.1001/archneur.56.1.84. View

17.

Wulff E, Wang A, Simpson D . HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000; 59(6):1251-60. DOI: 10.2165/00003495-200059060-00005. View

18.

Keswani S, Polley M, Pardo C, Griffin J, McArthur J, Hoke A . Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol. 2003; 54(3):287-96. DOI: 10.1002/ana.10645. View

19.

Lichtenstein K, Armon C, Baron A, Moorman A, Wood K, Holmberg S . Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis. 2004; 40(1):148-57. DOI: 10.1086/426076. View

20.

Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P . HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004; 61(4):546-51. DOI: 10.1001/archneur.61.4.546. View